Business Description
Accretion Nutraveda Ltd
ISIN : INE1KVQ01019
Total Employee Number:
18Compare
Compare
Traded in other countries / regions
544694.India IPO Date
2026-02-04Description
Accretion Nutraveda Ltd is engaged in the business of the Manufacturing of Ayurvedic and Nutraceutical products across several dosage forms, including Tablets, Capsules, Oral liquids, Oral Powders, External Preparation and Oils. It is a healthcare focused Company specializing in contract manufacturing, serving domestic as well as export markets in various countries like Sri Lanka, Singapore and the USA. The company offers a diverse range of dosage forms, leveraging both Classical Ayurvedic principles and modern nutraceutical science. Its product portfolio includes Tablets, such as film-coated and chewable varieties, for applications in liver care, gynecological care, bone and joint health, and respiratory support.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.3 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | 0.61 | |||||
Interest Coverage | 12.57 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 21.12 | |||||
Beneish M-Score | -2096.93 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 149.1 | |||||
3-Year EBITDA Growth Rate | 131 | |||||
3-Year EPS without NRI Growth Rate | 188.8 | |||||
3-Year Book Growth Rate | 413 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 79.35 | |||||
9-Day RSI | 70.07 | |||||
14-Day RSI | 64.72 | |||||
3-1 Month Momentum % | 0.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 14.27 | |||||
Quick Ratio | 10.73 | |||||
Cash Ratio | 0.5 | |||||
Days Inventory | 92.81 | |||||
Days Sales Outstanding | 70.05 | |||||
Days Payable | 22.89 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 27 | |||||
Operating Margin % | 19.43 | |||||
Net Margin % | 14.94 | |||||
EBITDA Margin % | 20.72 | |||||
FCF Margin % | -71.45 | |||||
OCF Margin % | -71.2 | |||||
ROE % | 30.69 | |||||
ROA % | 21.83 | |||||
ROIC % | 25.31 | |||||
3-Year ROIIC % | 13.26 | |||||
ROC (Joel Greenblatt) % | 41.38 | |||||
ROCE % | 36.21 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 36.62 | |||||
PE Ratio without NRI | 36.62 | |||||
PS Ratio | 5.43 | |||||
PB Ratio | 5.8 | |||||
Price-to-Tangible-Book | 5.79 | |||||
EV-to-EBIT | 31.18 | |||||
EV-to-EBITDA | 29.95 | |||||
EV-to-Revenue | 6.21 | |||||
EV-to-FCF | -8.38 | |||||
Price-to-Graham-Number | 3.07 | |||||
| Price-to-Net-Current-Asset-Value | 6.87 | |||||
Earnings Yield (Greenblatt) % | 3.2 | |||||
FCF Yield % | -11.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Accretion Nutraveda Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 336.03 | ||
| EPS (TTM) (₹) | 7.752 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 64.72 | ||
| 14-Day ATR (₹) | 6.593957 | ||
| 20-Day SMA (₹) | 267.3475 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (₹) | 150.1 - 300 | ||
| Shares Outstanding (Mil) | 7.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Accretion Nutraveda Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Accretion Nutraveda Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Accretion Nutraveda Ltd Frequently Asked Questions
What is Accretion Nutraveda Ltd(BOM:544694)'s stock price today?
The current price of BOM:544694 is ₹283.95. The 52 week high of BOM:544694 is ₹300.00 and 52 week low is ₹150.10.
When is next earnings date of Accretion Nutraveda Ltd(BOM:544694)?
The next earnings date of Accretion Nutraveda Ltd(BOM:544694) is .
Does Accretion Nutraveda Ltd(BOM:544694) pay dividends? If so, how much?
Accretion Nutraveda Ltd(BOM:544694) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Accretion Nutraveda Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers